ATRA vs. RLMD
ATRA (Atara Biotherapeutics, Inc.) and RLMD (Relmada Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ATRA returned -34.79%/yr vs -3.05%/yr for RLMD. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
ATRA vs. RLMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATRA achieves a -53.68% return, which is significantly lower than RLMD's 9.94% return. Over the past 10 years, ATRA has underperformed RLMD with an annualized return of -34.79%, while RLMD has yielded a comparatively higher -3.05% annualized return.
ATRA
- 1D
- 2.57%
- 1M
- -28.07%
- 6M
- 61.15%
- YTD
- -53.68%
- 1Y
- -27.45%
- 3Y*
- -46.18%
- 5Y*
- -51.70%
- 10Y*
- -34.79%
- ALL TIME*
- -24.96%
RLMD
- 1D
- -0.75%
- 1M
- -15.45%
- 6M
- 49.58%
- YTD
- 9.94%
- 1Y
- 799.39%
- 3Y*
- 27.53%
- 5Y*
- -27.22%
- 10Y*
- -3.05%
- ALL TIME*
- -18.56%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $466.37K | $668.90K | $13.86M | |
| $8.35M | $9.37M | $10.80M |
ATRA vs. RLMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ATRA Atara Biotherapeutics, Inc. | -53.68% | 35.91% | 3.82% | -84.37% | -79.19% | -19.71% | 19.19% | -52.59% | 91.93% | 27.46% |
RLMD Relmada Therapeutics, Inc. | 9.94% | 828.85% | -87.44% | 18.62% | -84.51% | -29.75% | -17.77% | 747.83% | 53.33% | -31.19% |
Correlation
The correlation between ATRA and RLMD is 0.28, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.28 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2014 | 0.14 |
The correlation between ATRA and RLMD shifts across timeframes, from 0.14 (all time) to 0.28 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ATRA:
$75.51M
RLMD:
$556.97M
ATRA:
-$0.70
RLMD:
-$0.94
ATRA:
$22.62M
RLMD:
$0.00
ATRA:
$21.73M
RLMD:
$0.00
ATRA:
-$6.92M
RLMD:
-$60.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATRA vs. RLMD — Risk / Return Rank
ATRA
RLMD
ATRA vs. RLMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atara Biotherapeutics, Inc. (ATRA) and Relmada Therapeutics, Inc. (RLMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATRA | RLMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -6.63 | ||
| Sortino ratioReturn per unit of downside risk | -4.84 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.63 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.36 | 20.90 | -21.26 |
| Martin ratioReturn relative to average drawdown | -0.58 | 53.87 | -54.45 |
Loading charts...
Drawdowns
ATRA vs. RLMD - Drawdown Comparison
The maximum ATRA drawdown since its inception was -99.74%, roughly equal to the maximum RLMD drawdown of -99.66%. Use the drawdown chart below to compare losses from any high point for ATRA and RLMD.
Loading charts...
Drawdown Indicators
| ATRA | RLMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.74% | -99.66% | -0.08% |
Max Drawdown (1Y)Largest decline over 1 year | -76.89% | -36.39% | -40.50% |
Max Drawdown (3Y)Largest decline over 3 years | -92.73% | -96.30% | +3.57% |
Max Drawdown (5Y)Largest decline over 5 years | -99.16% | -99.32% | +0.16% |
Max Drawdown (10Y)Largest decline over 10 years | -99.68% | -99.50% | -0.18% |
Current DrawdownCurrent decline from peak | -99.48% | -92.86% | -6.62% |
Average DrawdownAverage peak-to-trough decline | -74.31% | -79.84% | +5.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.23% | 14.10% | +33.13% |
Volatility
ATRA vs. RLMD - Volatility Comparison
Atara Biotherapeutics, Inc. (ATRA) has a higher volatility of 21.45% compared to Relmada Therapeutics, Inc. (RLMD) at 18.23%. This indicates that ATRA's price experiences larger fluctuations and is considered to be riskier than RLMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATRA | RLMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.45% | 18.23% | +3.22% |
Volatility (6M)Calculated over the trailing 6-month period | 92.58% | 68.22% | +24.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 143.69% | 118.22% | +25.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 122.28% | 116.44% | +5.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 100.43% | 114.21% | -13.78% |
Dividends
ATRA vs. RLMD - Dividend Comparison
Neither ATRA nor RLMD has paid dividends to shareholders.
Financials
ATRA vs. RLMD - Financials Comparison
This section allows you to compare key financial metrics between Atara Biotherapeutics, Inc. and Relmada Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATRA and RLMD have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATRA has higher volatility (21.45%) compared to RLMD (18.23%). In terms of maximum drawdown, ATRA dropped -99.74% vs RLMD's -99.66%.
RLMD currently has the higher Sharpe Ratio (6.44 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATRA and RLMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer